RBx-10017876

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRBx-10017876
Drug Alias NamePDE 4 inhibitors (Ranbaxy)RBx-11082RBx-14016
ClassificationSmall molecules
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRanbaxy Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRanbaxy Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A